Aroten HCT Tablet 5/20/12.5 mg

Adult dosage

This medication should be taken once daily, with or without food, along with water. It is recommended to take it at the same time daily, if possible (e.g., in the morning). The recommended doses are as follows: - 5/20/12.5 mg: Administer for patients whose blood pressure is inadequately controlled with amlodipine/olmesartan medoxomil 5/20 mg combination therapy. - 5/40/12.5 mg: Administer for patients whose blood pressure is inadequately controlled with amlodipine/olmesartan medoxomil 5/40 mg.

Children's dosage

Safety and efficacy for pediatric patients under 18 years of age have not been established; therefore, the use of this medication is not recommended.

This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the ingredients or similar ingredients or those with certain health conditions should not take this medication. In particular, patients with severe hypotension, severe kidney or liver disease, or certain heart diseases should not use this medication. Patients with low blood volume or salt deficiency may experience hypotension upon initial dosing, necessitating careful monitoring. Patients with weakened kidney function or those who have received kidney transplants should regularly check their kidney function and electrolyte status through blood tests. Patients with liver disease, heart valve disease, and certain autoimmune diseases should also use this medication with caution. This drug can cause electrolyte imbalance, so care should be taken against hypokalemia, hyperkalemia, hyponatremia, and hypercalcemia. Dizziness or drowsiness may occur during treatment, making it unsafe to drive or operate hazardous machinery. This medication can cause photosensitivity reactions; therefore, patients should avoid sun exposure and discontinue use if adverse reactions occur. Regular monitoring of blood pressure and blood tests to evaluate kidney function and electrolyte status during treatment is important. Patients with diabetes or impaired kidney function should consult a doctor before using this medication, and it is necessary to inform the healthcare provider about potential drug interactions. Use of this medication is not recommended during breastfeeding, and safety has not been established in pediatric patients, so it is best to avoid prescribing it to them. In case of overdose, hypotension and heart problems may occur, requiring immediate medical assistance. This medication should be stored out of reach of children and protected from moisture, heat, and direct sunlight.

Serious side effects

Urticaria, angioedema, Quincke's edema, severe swelling (edema), tightness in the chest, difficulty breathing, anaphylaxis, acute respiratory distress syndrome (ARDS), acute interstitial pneumonia, pulmonary edema, jaundice, myocardial infarction, arrhythmia, angina, hypotension, thrombosis, embolism, Stevens-Johnson syndrome, vasculitis (including necrotizing vasculitis), convulsions, altered consciousness (such as loss of consciousness), syncope, jaundice

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• rhinitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication is sensitive to air and moisture; thus, it should be stored in a tightly sealed container. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the drug's effectiveness and safety.

Appearance

White and orange round film-coated tablet

Package unit

28 tablets (14 tablets/PTP × 2)/carton